SCHEMBL7985168

SCHEMBL7985168

Cc1ccc(Cn2cnc3[nH]c(-c4ccc(F)cc4)nc(=O)c32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
KDM4E B2RXH2 3/20 0.43
P2RX7 Q99572 2/20 0.40
CNOT7 Q9UIV1 2/20 0.39
PARN O95453 1/20 0.39
MAPT P10636 2/20 0.38
RET P07949 1/20 0.38
KDR P35968 1/20 0.38
RIPK3 Q9Y572 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ACP1 P24666 2/20 0.38
TP53 P04637 1/20 0.38
MAPK13 O15264 1/20 0.38
GCGR P47871 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38
SOS1 Q07889 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984283 0.94 CNOT7 (0.43) KMT2AMEN1KDM4EP2RX7CNOT7
SCHEMBL7985065 0.90 CNOT7 (0.40) KMT2AMEN1CNOT7PARNMAPT
SCHEMBL7974508 0.89 CNOT7 (0.51) KMT2AKDM4ECNOT7PARNALDH1A1
SCHEMBL7986522 0.89 CNOT7 (0.48) KMT2AMEN1KDM4EP2RX7CNOT7
SCHEMBL7984720 0.89 CNOT7 (0.48) CNOT7PARNALDH1A1ACP1TP53
SCHEMBL7987364 0.88 TNKS (0.46) KDM4ECNOT7PARNRIPK3ALDH1A1
SCHEMBL7985279 0.88 CNOT7 (0.49) KDM4ECNOT7PARNMAPK13GCGR
SCHEMBL7985827 0.88 CNOT7 (0.49) KMT2AKDM4ECNOT7PARNMAPT
SCHEMBL7988570 0.87 HPGD (0.47) KMT2AMEN1KDM4EP2RX7CNOT7
SCHEMBL7974471 0.87 ACP1 (0.43) KMT2AMEN1KDM4EP2RX7CNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed